Company Profile
Control Bionics provides the research, development, commercialization, and sale of assistive communications technology systems globally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices the NeuroStrip, a wearable, miniaturized electromyography device.
Its portfolio also includes NeuroNode, a wireless, wearable sensor that allows users to access technology through bioelectric signals and spatial movements, and Cosmos Connect, a small portable control device that turns a single NeuroNode sensor into multiple outputs.
Additionally, it offers mounting systems under the Rehadapt brand, including wheelchair mounts, floor stands, and table stands. Its portfolio also includes switch systems comprising proximity, press, and finger switches, and the autonomous wheelchair module under the DROVE brand. Incorporated in 2005 and headquartered in Cremorne, Australia, Control Bionics was formerly known as Control Bionics Holdings Pty Limited before rebranding in September 2020.